Monthly Archives: December 2017

Portfolio Scorecard: Atlas’ Biotech Seed Class of 2013
December 13, 2017

Four years ago, in December 2013, I highlighted Atlas’ seed-led venture creation model by walking through our Fund IX Seed Class of 2013.  Only a short 1400 days ago, reading it again last week made it seem like an eternity.

Leave a comment

Operating Systems For Living Medicines
December 6, 2017

This blog was written by Mike Gilman, CEO of Obsidian Therapeutics and Atlas Advisor, as part of the From The Trenches feature of LifeSciVC. Consider the leech – the first living medicine. In its heyday in the 19th century –

1 Comment